Table 1 Variants in non-coding RNA and their targets.
Mutations | ncRNA with exonic variants | Regulatory targets | Target gene function |
|---|---|---|---|
chr6:30291803-T-G | HCG18 | FGFR1 | Involved in multiple mental disorders, including depression, bipolar disorder, and schizophrenia |
chr5:43573385-A-G; chr5:43573453-CAAAG-C; chr5:43573599-G-A; chr5:43574087-T-C; chr5:43574806-C-G; chr5:43602972-C-T | NNT-AS1 | SMAD4 | Gene expression altered in the blood and brain of schizophrenia patients |
chr21:43809225-C-G; chr21:43811039-C-T; chr21:43811979-C-T; chr21:43812406-G-A | AATBC | NFE2L2 | Involved in the oxidative stress and psychiatric disorders and a potential therapeutic target |
chr18:1276085-A-G | LINC00470 | ILF3 | Significantly associated with the risk of bipolar disorder |
chr4:1218202-G-A | CTBP1-AS | miR-940 | Differentially expressed in major depression disorders |
chr21:20781609-C-T | LINC00320 | CTNNB1 | Mutations of CTNNB1 lead to dysfunction in the Wnt signaling pathway, which regulates gene transcription and further disturbs synaptic plasticity, neuronal apoptosis, and neurogenesis. |